|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 400 out of 465 for Pik3cd

0.049s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_10
Specimen Label: euxassay_012716_10
Detected: true
Specimen Num: 10
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_11
Specimen Label: euxassay_012716_11
Detected: true
Specimen Num: 11
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_12
Specimen Label: euxassay_012716_12
Detected: true
Specimen Num: 12
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_13
Specimen Label: euxassay_012716_13
Detected: true
Specimen Num: 13
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_14
Specimen Label: euxassay_012716_14
Detected: true
Specimen Num: 14
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_15
Specimen Label: euxassay_012716_15
Detected: true
Specimen Num: 15
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_16
Specimen Label: euxassay_012716_16
Detected: true
Specimen Num: 16
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_17
Specimen Label: euxassay_012716_17
Detected: true
Specimen Num: 17
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_18
Specimen Label: euxassay_012716_18
Detected: true
Specimen Num: 18
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_19
Specimen Label: euxassay_012716_19
Detected: true
Specimen Num: 19
GXD Expression  
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1689423
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4827207
Age: embryonic day 14.5
Image: euxassay_012716_20
Specimen Label: euxassay_012716_20
Detected: true
Specimen Num: 20
GXD Expression    
Probe: MGI:5001923
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Absent
Sex: Female
Emaps: EMAPS:1796223
Stage: TS23
Assay Id: MGI:5542477
Age: embryonic day 15.5
Image: GUDMAP:10980
Specimen Label: GUDMAP:10980
Detected: false
Specimen Num: 2
GXD Expression    
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1768022
Stage: TS22
Assay Id: MGI:5422279
Age: embryonic day 14.5
Note: Expression was not detected in the skull (base and vault).
Specimen Label: ES2288; Specimen S889
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:4425091
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:2672022
Stage: TS22
Assay Id: MGI:5422279
Age: embryonic day 14.5
Note: Expression was not detected in whisker follicle.
Specimen Label: ES2288; Specimen S889
Detected: false
Specimen Num: 1
Publication
First Author: Takahashi K
Year: 2003
Journal: Nature
Title: Role of ERas in promoting tumour-like properties in mouse embryonic stem cells.
Volume: 423
Issue: 6939
Pages: 541-5
Publication
First Author: Onyilagha C
Year: 2015
Journal: PLoS Negl Trop Dis
Title: The B cell adaptor molecule Bam32 is critically important for optimal antibody response and resistance to Trypanosoma congolense infection in mice.
Volume: 9
Issue: 4
Pages: e0003716
Publication
First Author: Puri KD
Year: 2004
Journal: Blood
Title: Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue.
Volume: 103
Issue: 9
Pages: 3448-56
Publication  
First Author: Manda-Handzlik A
Year: 2022
Journal: Int J Mol Sci
Title: Lack of Functional P110δ Affects Expression of Activation Marker CD80 but Does Not Influence Functions of Neutrophils.
Volume: 23
Issue: 12
Publication
First Author: Carter MJ
Year: 2017
Journal: Leukemia
Title: PI3Kδ inhibition elicits anti-leukemic effects through Bim-dependent apoptosis.
Volume: 31
Issue: 6
Pages: 1423-1433
Publication
First Author: Clayton E
Year: 2002
Journal: J Exp Med
Title: A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation.
Volume: 196
Issue: 6
Pages: 753-63
Publication
First Author: Webb LM
Year: 2005
Journal: J Immunol
Title: Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase.
Volume: 175
Issue: 5
Pages: 2783-7
Publication
First Author: Jarmin SJ
Year: 2008
Journal: J Clin Invest
Title: T cell receptor-induced phosphoinositide-3-kinase p110delta activity is required for T cell localization to antigenic tissue in mice.
Volume: 118
Issue: 3
Pages: 1154-64
Publication
First Author: Saudemont A
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease.
Volume: 106
Issue: 14
Pages: 5795-800
Publication
First Author: Ali K
Year: 2014
Journal: Nature
Title: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.
Volume: 510
Issue: 7505
Pages: 407-411
Publication
First Author: Patton DT
Year: 2006
Journal: J Immunol
Title: Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells.
Volume: 177
Issue: 10
Pages: 6598-602
Publication
First Author: Ali K
Year: 2008
Journal: J Immunol
Title: Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo.
Volume: 180
Issue: 4
Pages: 2538-44
Publication
First Author: Thomas MJ
Year: 2005
Journal: Eur J Immunol
Title: Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases.
Volume: 35
Issue: 4
Pages: 1283-91
Publication
First Author: Fruman DA
Year: 2011
Journal: Cancer Discov
Title: PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic.
Volume: 1
Issue: 7
Pages: 562-72
Publication
First Author: Ji H
Year: 2007
Journal: Blood
Title: Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation.
Volume: 110
Issue: 8
Pages: 2940-7
Publication
First Author: Senis YA
Year: 2005
Journal: Platelets
Title: Role of the p110delta PI 3-kinase in integrin and ITAM receptor signalling in platelets.
Volume: 16
Issue: 3-4
Pages: 191-202
Publication
First Author: Liu D
Year: 2009
Journal: J Immunol
Title: The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells.
Volume: 183
Issue: 3
Pages: 1921-33
Publication
First Author: Hao L
Year: 2019
Journal: J Leukoc Biol
Title: Critical role for PI3Kγ-dependent neutrophil reactive oxygen species in WKYMVm-induced microvascular hyperpermeability.
Volume: 106
Issue: 5
Pages: 1117-1127
Publication
First Author: Zotes TM
Year: 2013
Journal: PLoS One
Title: PI3K p110δ is expressed by gp38(-)CD31(+) and gp38(+)CD31(+) spleen stromal cells and regulates their CCL19, CCL21, and LTβR mRNA levels.
Volume: 8
Issue: 8
Pages: e72960
Publication
First Author: Zebedin E
Year: 2008
Journal: Blood
Title: Leukemic challenge unmasks a requirement for PI3Kdelta in NK cell-mediated tumor surveillance.
Volume: 112
Issue: 12
Pages: 4655-64
Publication
First Author: Jou ST
Year: 2002
Journal: Mol Cell Biol
Title: Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex.
Volume: 22
Issue: 24
Pages: 8580-91
Publication
First Author: Beer-Hammer S
Year: 2010
Journal: J Leukoc Biol
Title: The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation.
Volume: 87
Issue: 6
Pages: 1083-95
Publication
First Author: Tassi I
Year: 2007
Journal: Immunity
Title: p110gamma and p110delta phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells.
Volume: 27
Issue: 2
Pages: 214-27
Publication
First Author: Mothes B
Year: 2016
Journal: PLoS One
Title: p110γ/δ Double-Deficiency Induces Eosinophilia and IgE Production but Protects from OVA-Induced Airway Inflammation.
Volume: 11
Issue: 7
Pages: e0159310
Publication
First Author: Llorian M
Year: 2007
Journal: J Immunol
Title: The PI3K p110delta is required for down-regulation of RAG expression in immature B cells.
Volume: 178
Issue: 4
Pages: 1981-5
Publication
First Author: Randis TM
Year: 2008
Journal: Eur J Immunol
Title: Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils.
Volume: 38
Issue: 5
Pages: 1215-24
Publication
First Author: Glassford J
Year: 2005
Journal: Eur J Immunol
Title: Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes.
Volume: 35
Issue: 9
Pages: 2748-61
Publication
First Author: Swat W
Year: 2006
Journal: Blood
Title: Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival.
Volume: 107
Issue: 6
Pages: 2415-22
Publication
First Author: Kim N
Year: 2007
Journal: Blood
Title: The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion.
Volume: 110
Issue: 9
Pages: 3202-8
Publication
First Author: Patton DT
Year: 2011
Journal: PLoS One
Title: The PI3K p110δ regulates expression of CD38 on regulatory T cells.
Volume: 6
Issue: 3
Pages: e17359
Publication
First Author: Jayachandran N
Year: 2017
Journal: Eur J Immunol
Title: B-cell-intrinsic function of TAPP adaptors in controlling germinal center responses and autoantibody production in mice.
Volume: 47
Issue: 2
Pages: 280-290
Publication
First Author: Kulkarni S
Year: 2011
Journal: Sci Signal
Title: PI3Kβ plays a critical role in neutrophil activation by immune complexes.
Volume: 4
Issue: 168
Pages: ra23
Publication
First Author: Gollmer K
Year: 2009
Journal: Blood
Title: CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway.
Volume: 114
Issue: 3
Pages: 580-8
Publication
First Author: Soler A
Year: 2013
Journal: J Exp Med
Title: Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis.
Volume: 210
Issue: 10
Pages: 1937-45
Publication  
First Author: Hemmati S
Year: 2019
Journal: JCI Insight
Title: PI3 kinase alpha and delta promote hematopoietic stem cell activation.
Volume: 5
Issue: 13
Publication
First Author: Puri KD
Year: 2005
Journal: Blood
Title: The role of endothelial PI3Kgamma activity in neutrophil trafficking.
Volume: 106
Issue: 1
Pages: 150-7
Publication
First Author: Wang HB
Year: 2007
Journal: Nat Immunol
Title: P-selectin primes leukocyte integrin activation during inflammation.
Volume: 8
Issue: 8
Pages: 882-92
Publication
First Author: Garçon F
Year: 2016
Journal: Immunol Cell Biol
Title: PI3Kδ promotes CD4(+) T-cell interactions with antigen-presenting cells by increasing LFA-1 binding to ICAM-1.
Volume: 94
Issue: 5
Pages: 486-95
Publication
First Author: Houslay DM
Year: 2016
Journal: Sci Signal
Title: Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells.
Volume: 9
Issue: 441
Pages: ra82
Publication
First Author: Roller A
Year: 2012
Journal: J Immunol
Title: Blockade of phosphatidylinositol 3-kinase PI3Kδ or PI3Kγ reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis.
Volume: 189
Issue: 9
Pages: 4612-20
Publication
First Author: Zhang TT
Year: 2012
Journal: J Immunol
Title: p110δ phosphoinositide 3-kinase represses IgE switch by potentiating BCL6 expression.
Volume: 188
Issue: 8
Pages: 3700-8
Publication
First Author: Konrad S
Year: 2008
Journal: J Biol Chem
Title: Phosphoinositide 3-kinases gamma and delta, linkers of coordinate C5a receptor-Fcgamma receptor activation and immune complex-induced inflammation.
Volume: 283
Issue: 48
Pages: 33296-303
Publication
First Author: Jackson SP
Year: 2005
Journal: Nat Med
Title: PI 3-kinase p110beta: a new target for antithrombotic therapy.
Volume: 11
Issue: 5
Pages: 507-14
Publication
First Author: Chantry D
Year: 1997
Journal: J Biol Chem
Title: p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes.
Volume: 272
Issue: 31
Pages: 19236-41
Publication
First Author: Ali K
Year: 2004
Journal: Nature
Title: Essential role for the p110delta phosphoinositide 3-kinase in the allergic response.
Volume: 431
Issue: 7011
Pages: 1007-11
Publication
First Author: Stark AK
Year: 2020
Journal: J Immunol
Title: Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation.
Volume: 205
Issue: 1
Pages: 78-89
Publication
First Author: Foukas LC
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Activity of any class IA PI3K isoform can sustain cell proliferation and survival.
Volume: 107
Issue: 25
Pages: 11381-6
Publication
First Author: Goodwin CB
Year: 2014
Journal: Blood
Title: PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML.
Volume: 123
Issue: 18
Pages: 2838-42
Publication
First Author: Akula MK
Year: 2016
Journal: Nat Immunol
Title: Control of the innate immune response by the mevalonate pathway.
Volume: 17
Issue: 8
Pages: 922-9
Publication
First Author: Stark AK
Year: 2018
Journal: Nat Commun
Title: PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner.
Volume: 9
Issue: 1
Pages: 3174
Publication
First Author: Chiao PJ
Year: 2011
Journal: Cancer Discov
Title: Kras, Pten, NF-κB, and inflammation: dangerous liaisons.
Volume: 1
Issue: 2
Pages: 103-5
Publication    
First Author: Iacono A
Year: 2020
Journal: EMBO Rep
Title: Class IA PI3Ks regulate subcellular and functional dynamics of IDO1.
Pages: e49756
Publication
First Author: Aksoy E
Year: 2012
Journal: Nat Immunol
Title: The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.
Volume: 13
Issue: 11
Pages: 1045-1054
Publication
First Author: Kishimoto H
Year: 2007
Journal: Blood
Title: The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells.
Volume: 109
Issue: 8
Pages: 3316-24
Publication
First Author: Garçon F
Year: 2008
Journal: Blood
Title: CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer.
Volume: 111
Issue: 3
Pages: 1464-71
Publication
First Author: Rolf J
Year: 2010
Journal: J Immunol
Title: Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction.
Volume: 185
Issue: 7
Pages: 4042-52
Publication
First Author: Mauro C
Year: 2017
Journal: Cell Metab
Title: Obesity-Induced Metabolic Stress Leads to Biased Effector Memory CD4+ T Cell Differentiation via PI3K p110δ-Akt-Mediated Signals.
Volume: 25
Issue: 3
Pages: 593-609
Publication
First Author: Gross C
Year: 2015
Journal: Cell Rep
Title: Selective role of the catalytic PI3K subunit p110β in impaired higher order cognition in fragile X syndrome.
Volume: 11
Issue: 5
Pages: 681-8
Publication
First Author: Compagno M
Year: 2017
Journal: Nature
Title: Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.
Volume: 542
Issue: 7642
Pages: 489-493
Publication  
First Author: Zhou T
Year: 2018
Journal: EBioMedicine
Title: Runt-Related Transcription Factor 1 (RUNX1) Promotes TGF-β-Induced Renal Tubular Epithelial-to-Mesenchymal Transition (EMT) and Renal Fibrosis through the PI3K Subunit p110δ.
Volume: 31
Pages: 217-225
Publication
First Author: Sinclair LV
Year: 2008
Journal: Nat Immunol
Title: Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking.
Volume: 9
Issue: 5
Pages: 513-21
Publication
First Author: Finlay DK
Year: 2012
Journal: J Exp Med
Title: PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
Volume: 209
Issue: 13
Pages: 2441-53
Publication
First Author: Uehara M
Year: 2017
Journal: Nat Commun
Title: Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.
Volume: 8
Issue: 1
Pages: 951
Publication
First Author: Henley T
Year: 2008
Journal: Eur J Immunol
Title: B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta.
Volume: 38
Issue: 12
Pages: 3543-8
Publication
First Author: Janas ML
Year: 2008
Journal: J Immunol
Title: The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells.
Volume: 180
Issue: 2
Pages: 739-46
Publication
First Author: Zheng L
Year: 2015
Journal: Arterioscler Thromb Vasc Biol
Title: Inactivation of PI3Kδ induces vascular injury and promotes aneurysm development by upregulating the AP-1/MMP-12 pathway in macrophages.
Volume: 35
Issue: 2
Pages: 368-77
Publication
First Author: Liu S
Year: 2011
Journal: PLoS One
Title: The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis.
Volume: 6
Issue: 3
Pages: e17161
Publication  
First Author: Oka A
Year: 2019
Journal: Cells
Title: Phosphoinositide 3-Kinase P110δ-Signaling Is Critical for Microbiota-Activated IL-10 Production by B Cells that Regulate Intestinal Inflammation.
Volume: 8
Issue: 10
Publication
First Author: Attridge K
Year: 2014
Journal: J Immunol
Title: IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells.
Volume: 192
Issue: 5
Pages: 2195-201
Publication
First Author: Dil N
Year: 2009
Journal: Mol Immunol
Title: Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
Volume: 46
Issue: 10
Pages: 1970-8
Publication
First Author: Juss JK
Year: 2012
Journal: PLoS One
Title: Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival.
Volume: 7
Issue: 9
Pages: e45933
Publication
First Author: Papakonstanti EA
Year: 2008
Journal: J Cell Sci
Title: Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages.
Volume: 121
Issue: Pt 24
Pages: 4124-33
Publication
First Author: Mattila PK
Year: 2013
Journal: Immunity
Title: The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling.
Volume: 38
Issue: 3
Pages: 461-74
Publication
First Author: Schoenwaelder SM
Year: 2007
Journal: J Biol Chem
Title: Identification of a unique co-operative phosphoinositide 3-kinase signaling mechanism regulating integrin alpha IIb beta 3 adhesive function in platelets.
Volume: 282
Issue: 39
Pages: 28648-58
Publication
First Author: Foukas LC
Year: 2006
Journal: Nature
Title: Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.
Volume: 441
Issue: 7091
Pages: 366-70
Publication
First Author: Schoenwaelder SM
Year: 2010
Journal: J Biol Chem
Title: Phosphoinositide 3-kinase p110 beta regulates integrin alpha IIb beta 3 avidity and the cellular transmission of contractile forces.
Volume: 285
Issue: 4
Pages: 2886-96
Publication
First Author: Ramadani F
Year: 2010
Journal: Sci Signal
Title: The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development.
Volume: 3
Issue: 134
Pages: ra60
Publication
First Author: Goossens P
Year: 2019
Journal: Cell Metab
Title: Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression.
Volume: 29
Issue: 6
Pages: 1376-1389.e4
Publication  
First Author: Yuzugullu H
Year: 2015
Journal: Nat Commun
Title: A PI3K p110β-Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis.
Volume: 6
Pages: 8501
Publication
First Author: Arana E
Year: 2008
Journal: Immunity
Title: Activation of the small GTPase Rac2 via the B cell receptor regulates B cell adhesion and immunological-synapse formation.
Volume: 28
Issue: 1
Pages: 88-99
Publication
First Author: Huntington ND
Year: 2007
Journal: Nat Immunol
Title: Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1.
Volume: 8
Issue: 8
Pages: 856-63
Publication
First Author: Gayral S
Year: 2014
Journal: Cardiovasc Res
Title: Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kγ pathway.
Volume: 102
Issue: 1
Pages: 118-27
Publication
First Author: Anderson KE
Year: 2008
Journal: Blood
Title: CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks.
Volume: 112
Issue: 13
Pages: 5202-11
Publication
First Author: Macintyre AN
Year: 2011
Journal: Immunity
Title: Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism.
Volume: 34
Issue: 2
Pages: 224-36
Publication
First Author: Janas ML
Year: 2011
Journal: J Immunol
Title: Interaction of Ras with p110γ is required for thymic β-selection in the mouse.
Volume: 187
Issue: 9
Pages: 4667-75
Publication
First Author: Janas ML
Year: 2010
Journal: J Exp Med
Title: Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4.
Volume: 207
Issue: 1
Pages: 247-61